Actively Recruiting

Age: 18Years +
All Genders
NCT04022109

Screening of Gastric Cancer Via Breath Volatile Organic Compounds by Hybrid Sensing Approach

Led by University of Latvia · Updated on 2021-07-26

5000

Participants Needed

5

Research Sites

369 weeks

Total Duration

On this page

Sponsors

U

University of Latvia

Lead Sponsor

T

Technion, Israel Institute of Technology

Collaborating Sponsor

AI-Summary

What this Trial Is About

The study is aimed to determine the potential of volatile marker testing for gastric cancer screening. The study will be addressing the role of confounding factors, including lifestyle factors, diet, smoking as well as addressing the potential role of microbiota in the composition of exhaled volatile markers.

CONDITIONS

Official Title

Screening of Gastric Cancer Via Breath Volatile Organic Compounds by Hybrid Sensing Approach

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with verified gastric cancer (Group 1 & 2)
  • Patients undergoing or having undergone upper endoscopy according to clinical indications (Group 3 & 5)
  • Average-risk population group aged 40-64 at inclusion without alarm symptoms (Group 4)
  • Motivation to participate in the study
  • Physical status allowing volatile marker sampling and other procedures within the protocol
  • Signed consent
Not Eligible

You will not qualify if you...

  • Known other active cancer
  • Ventilation problems, airway obstruction
  • Unwillingness or inability to co-operate

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 5 locations

1

A.C.Camargo Cancer Center

São Paulo, Brazil

Actively Recruiting

2

Pontificia Universidad Catolica de Chile

Santiago, Chile

Not Yet Recruiting

3

Centro Javeriano de Oncología, San Ignacio University Hospital

Bogotá, Colombia

Not Yet Recruiting

4

Institute of Clinical and Preventive Medicine, University of Latvia

Riga, Latvia, LV1050

Actively Recruiting

5

National Cancer Institute of Ukraine

Kiev, Ukraine

Actively Recruiting

Loading map...

Research Team

M

Marcis Leja, MD, PhD

CONTACT

D

Daiga Santare, MD, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

5

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here